Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales

    August 19, 2026

    SOUEAST UAE launches S08 Luxury following the success of the Flagship S08DM

    August 19, 2026
    Facebook X (Twitter) Instagram
    Rabat BuzzRabat Buzz
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Rabat BuzzRabat Buzz
    Home » Spinal cord therapy improves function using stem cells
    Featured News

    Spinal cord therapy improves function using stem cells

    March 24, 2025
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Stem cell treatment helps improve spinal cord injuries, according to a clinical study led by researchers at Keio University in Japan. The research marks the first time patients with spinal cord injuries have shown functional motor recovery following treatment with induced pluripotent stem cells (iPSCs). The team transplanted two million iPSC-derived cells into each of four patients who had lost movement and sensation due to spinal cord injuries.

    Spinal cord therapy improves function using stem cells

    One year after the procedure, two of the patients exhibited meaningful improvements in motor ability. The findings highlight how stem cell treatment helps improve spinal cord injuries in cases previously considered untreatable. One elderly patient, injured in an accident, progressed from the lowest motor function level, A, to level D, gaining the ability to stand without assistance. Another patient advanced to level C and regained the ability to eat independently.

    While the other two patients did not show improvement, none experienced serious side effects. Researchers noted that traditional rehabilitation yields a two-level recovery in only about 10 percent of cases classified at level A. These results suggest that the new treatment offers a significantly improved outlook, reinforcing the potential of regenerative medicine. Induced pluripotent stem cells are adult cells reprogrammed to an embryonic-like state, capable of transforming into a range of cell types.

    Their application in spinal cord injury therapy offers a promising and ethically sound alternative to embryonic stem cells. In Japan, where approximately 5,000 new spinal cord injuries are reported each year, the need for new therapies remains urgent. The team plans to begin formal clinical trials in pursuit of government approval for the treatment protocol. This breakthrough adds to the growing evidence that stem cell treatment helps improve spinal cord injuries, offering a new level of hope for recovery and mobility. – By MENA Newswire News Desk.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email

    Related Posts

    SOUEAST UAE launches S08 Luxury following the success of the Flagship S08DM

    August 19, 2026

    KoçSistem Leads Türkiye’s IT System Integrator for the Eighth Consecutive Year as KoçDigital Wins Top AI Award

    August 9, 2026

    Papa Johns teams up with Disney and Pixar for Toy Story 5

    August 7, 2026

    Heat intensifies severe drought across European nations

    July 24, 2026

    Amazon wildfires in Brazil fall to lowest level in four decades

    July 23, 2026

    Private sector wage growth hits six year low in latest UK data

    July 22, 2026
    Latest News
    Business

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Healthcare shares strengthen market gains
    Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026
    © 2026 Rabat Buzz | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.